0.00Open0.00Pre Close0 Volume0 Open Interest9.00Strike Price0.00Turnover230.41%IV-93.55%PremiumSep 20, 2024Expiry Date4.35Intrinsic Value100Multiplier26DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7811Delta0.1058Gamma1.01Leverage Ratio-0.0154Theta-0.0043Rho-0.79Eff Leverage0.0036Vega
Lantern Pharma Stock Discussion
Lantern Pharma Highlights Promising Preclinical Results of LP-184’s Synergy with Checkpoint Inhibitors & Sensitizing Tumors That are Non-Responsive to Anti-PD1 Therapy in Collaboration with MD Anderson at Immuno-Oncology Summit 2024
Lantern Pharma (NASDAQ: LTRN) announced promising preclinical results for LP-184, demonstrating synergy with checkpoint inhibitors and the ability to resensitize tumors non-responsive to Anti-PD1 therapies. Key findings include:
1. LP-18...
Lantern Pharma, a company specializing in the use of artificial intelligence (AI) for the development of cancer therapies, has recently shared promising preliminary results from its ongoing Phase 2 HARMONIC™ clinical trial. This study focuses on never smokers with advanced NSCLC, specifically lung adenocarcinoma, who have devel...
Lantern Pharma Achieves Key Milestone Towards Development of Molecular Diagnostic for use in Oncology Clinical Trials for Patient Selection and Stratification with Drug Candidate LP-184
Lantern Pharma (NASDAQ: LTRN) has achieved a milestone in developing a qRT-PCR-based diagnostic for its drug candidate, LP-184. This diagnostic quantifies PTGR1 RNA in tumor samples, helping identify patients likely to respond to LP-184 across various solid tumors. Successful confirm...
Lantern Pharma Receives Certificate of Patent from Japanese Patent Office (JPO) for Composition of Matter Covering Drug Candidate LP-284
NEWS
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism
NEWS
Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan
( HOLO - LYT - PIXY - PIK - SWIN - WORX - VINC - SMR - AVD - BMR - HEAR - GXAI - APM - RYDE - LTRN - MEDS...) IF KEEP BUYING 👉THEN THEY MUST GO DOWN (TO $1 AND DELETE = NES ) BECAUSE CHEATERS BLOCK ( SHORT = LAO ) TRAP TRADERS 👉 BUY ONLY 👉 ONE WAY TO HELL TO STEAL MONEY WITH PAPERS 😭👹😡👊👎
No comment yet